SINGAPORE (Reuters) -Southeast Asian ride-hailing and food delivery firm Grab is seeking a $750 million term loan, a term sheet showed on Monday after it announced that total group net revenue jumped by about 70% year-on-year in 2020 and had recovered to comfortably above pre-pandemic levels.
Delta Air Lines CEO Ed Bastian said in a memo on Friday that he continues to expect that the company will achieve positive cash flow by the spring.
HOUSTON (Reuters) -Exxon Mobil Corp signaled in a regulatory filing that higher oil and gas prices and improved chemicals margins would aid fourth quarter results, but the gains would be overshadowed by an up to $20 billion asset writedown.
Royal Dutch Shell on Monday said it will write down the value of oil and gas assets by $3.5 billion to $4.5 billion following a string of impairments this year as it adjusts to a weaker outlook.
Rolls-Royce may be the jewel in Britain's industrial crown, but the coronavirus crisis has left the engine-maker facing one of the toughest challenges in its 114-year history.
Consulting and outsourcing services provider Accenture Plc raised its full-year sales forecast and beat quarterly revenue estimates on Thursday, as an extended work-from-home period boosted its digital, cloud and security services.
The world's biggest advertising company WPP expects its net sales to return to pre-pandemic levels by 2022, a year earlier than expected, driven by the rapid global corporate switch to e-commerce and digital services.
Hong Kong's Cathay Pacific Airways Ltd expects a "significantly higher" second-half loss than its record first-half loss, driven by low demand, restructuring charges and impairments on its fleet of planes, it said on Wednesday.
Zara owner Inditex said many of its stores were closed or operating with restrictions as a fresh wave of COVID-19 lockdowns hindered the fashion giant's path to recovery.
Anglo American will divest from its South African and Colombian thermal coal operations by mid-2023, the miner said on Friday as it sought to demonstrate to investors its commitment to a shift towards clean energy sources.
A top executive at an Indian biotechnology company defended its COVID-19 vaccine candidate, approved for emergency use by the government, and said it will produce efficacy data from late-stage trials by March.